Annual ROE
-97.84%
-36.03%-58.29%
31 December 2023
Summary:
Cardiol Therapeutics annual return on equity is currently -97.84%, with the most recent change of -36.03% (-58.29%) on 31 December 2023. During the last 3 years, it has risen by +50.19% (+33.91%). CRDL annual ROE is now -73.26% below its all-time high of -56.47%, reached on 01 December 2017.CRDL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-192.90%
-74.28%-62.62%
30 September 2024
Summary:
Cardiol Therapeutics quarterly return on equity is currently -192.90%, with the most recent change of -74.28% (-62.62%) on 30 September 2024. Over the past year, it has dropped by -127.58% (-195.32%). CRDL quarterly ROE is now -103.62% below its all-time high of 5331.90%, reached on 01 September 2018.CRDL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.3% | -195.3% |
| 3 y3 years | +33.9% | -30.5% |
| 5 y5 years | -30.4% | -95.7% |
CRDL ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.3% | +33.9% | -329.9% | at low |
| 5 y | 5 years | -58.3% | +33.9% | -329.9% | at low |
| alltime | all time | -73.3% | +33.9% | -103.6% | at low |
Cardiol Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -192.90%(+62.6%) |
| June 2024 | - | -118.62%(+20.6%) |
| Mar 2024 | - | -98.38%(+29.8%) |
| Dec 2023 | -97.84%(+58.3%) | -75.81%(+16.1%) |
| Sept 2023 | - | -65.32%(+5.0%) |
| June 2023 | - | -62.19%(+16.0%) |
| Mar 2023 | - | -53.61%(+4.6%) |
| Dec 2022 | -61.81%(-14.0%) | -51.26%(+14.2%) |
| Sept 2022 | - | -44.87%(-16.1%) |
| June 2022 | - | -53.48%(-12.5%) |
| Mar 2022 | - | -61.10%(-24.7%) |
| Dec 2021 | -71.89% | - |
| Dec 2021 | - | -81.14%(-45.1%) |
| Sept 2021 | - | -147.77%(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | -134.15%(+0.1%) |
| Mar 2021 | - | -134.07%(+19.0%) |
| Dec 2020 | -148.03%(+61.3%) | -112.68%(+51.1%) |
| Sept 2020 | - | -74.57%(-1.3%) |
| June 2020 | - | -75.54%(-9.1%) |
| Mar 2020 | - | -83.11%(+11.2%) |
| Dec 2019 | -91.79%(+22.4%) | -74.75%(-24.2%) |
| Sept 2019 | - | -98.56%(-30.2%) |
| June 2019 | - | -141.22%(-0.2%) |
| Mar 2019 | - | -141.53%(-18.9%) |
| Dec 2018 | -75.00%(+32.8%) | -174.58%(-103.3%) |
| Sept 2018 | - | 5331.90%(-5185.7%) |
| June 2018 | - | -104.84%(+79.3%) |
| Mar 2018 | - | -58.46%(+49.1%) |
| Dec 2017 | -56.47% | -39.21% |
FAQ
- What is Cardiol Therapeutics annual return on equity?
- What is the all time high annual ROE for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual ROE year-on-year change?
- What is Cardiol Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly ROE year-on-year change?
What is Cardiol Therapeutics annual return on equity?
The current annual ROE of CRDL is -97.84%
What is the all time high annual ROE for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual return on equity is -56.47%
What is Cardiol Therapeutics annual ROE year-on-year change?
Over the past year, CRDL annual return on equity has changed by -36.03% (-58.29%)
What is Cardiol Therapeutics quarterly return on equity?
The current quarterly ROE of CRDL is -192.90%
What is the all time high quarterly ROE for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly return on equity is 5331.90%
What is Cardiol Therapeutics quarterly ROE year-on-year change?
Over the past year, CRDL quarterly return on equity has changed by -127.58% (-195.32%)